Survival Outcomes Associated With Clinical and Pathological Response Following Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Chemotherapy in Resected Pancreatic Cancer-Reference-Cited by-同舟云学术

Survival Outcomes Associated With Clinical and Pathological Response Following Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Chemotherapy in Resected Pancreatic Cancer

Published:2019-09 Issue:3 Volume:270 Page:400-413
ISSN:0003-4932
Container-title:Annals of Surgery
language:en
Short-container-title:

Author:

Macedo Francis I.,Ryon Emily,Maithel Shishir K.,Lee Rachel M.,Kooby David A.,Fields Ryan C.,Hawkins William G.,Williams Greg,Maduekwe Ugwuji,Kim Hong J.,Ahmad Syed A.,Patel Sameer H.,Abbott Daniel E.,Schwartz Patrick,Weber Sharon M.,Scoggins Charles R.,Martin Robert C. G.,Dudeja Vikas,Franceschi Dido,Livingstone Alan S.,Merchant Nipun B.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Surgery

Reference35 articles.

1. Cancer statistics, 2016;Siegel;CA Cancer J Clin,2016

2. Recent trends in survival of patients with pancreatic cancer in Germany and the United States;Sirri;Pancreas,2016

3. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States;Rahib;Cancer Res,2014

4. 1423 pancreaticoduodenectomies for pancreatic cancer: a single-institution experience;Winter;J Gastrointest Surg,2006

5. Preoperative radiochemotherapy versus surgery for resectable and borderline resectable pancreatic cancer (PREOPANC-1);van Tienhoven;J Clin Oncol,2018

Cited by 123 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overcoming therapy resistance in pancreatic cancer: New insights and future directions;Biochemical Pharmacology;2024-11

2. Impact of neoadjuvant chemoradiotherapy on pathologic response in pancreatic ductal adenocarcinoma: A systematic review and meta-analysis.;Pancreatology;2024-09

3. Lymph node metrics following neoadjuvant therapy to refine patient selection for adjuvant chemotherapy in resected pancreatic cancer: A multi‐institutional analysis;Journal of Surgical Oncology;2024-08-21

4. Outcomes of patients with initially unresectable pancreatic cancer who underwent conversion surgery after FOLFIRINOX or gemcitabine plus nab‐paclitaxel chemotherapy: A multicenter retrospective cohort study (PC‐CURE‐1);Journal of Hepato-Biliary-Pancreatic Sciences;2024-08-16

5. Complete pathological response to pembrolizumab in pretreated pancreatic acinar cell carcinoma;Journal of Cancer Research and Clinical Oncology;2024-07-11